Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia
Pflug, Natali, Bahlo, Jasmin, Shanafelt, Tait D., Eichhorst, Barbara F., Bergmann, Manuela A., Elter, Thomas, Bauer, Kathrin, Malchau, Gebhart, Rabe, Kari G., Stilgenbauer, Stephan, Döhner, Hartmut, Jäger, Ulrich, Eckart, Michael J., Hopfinger, Georg, Busch, Raymonde, Fink, Anna-Maria, Wendtner, Clemens-Martin, Fischer, Kirsten, Kay, Neil E., Hallek, Michael
Published in Blood (03.07.2014)
Published in Blood (03.07.2014)
Get full text
Journal Article
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
Eichhorst, Barbara F., Busch, Raymonde, Stilgenbauer, Stephan, Stauch, Martina, Bergmann, Manuela A., Ritgen, Matthias, Kranzhöfer, Nicole, Rohrberg, Robert, Söling, Ulrike, Burkhard, Oswald, Westermann, Anne, Goede, Valentin, Schweighofer, Carmen D., Fischer, Kirsten, Fink, Anna-Maria, Wendtner, Clemens M., Brittinger, Günter, Döhner, Hartmut, Emmerich, Bertold, Hallek, Michael
Published in Blood (15.10.2009)
Published in Blood (15.10.2009)
Get full text
Journal Article
Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group
Bergmann, MA, Goebeler, ME, Herold, M, Emmerich, B, Wilhelm, M, Ruelfs, C, Boening, L, Hallek, MJ, German CLL Study Group
Published in Haematologica (Roma) (01.10.2005)
Get full text
Published in Haematologica (Roma) (01.10.2005)
Journal Article
Evaluation of the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) in Elderly Patients with Comorbidities: Analysis of the CLL11 Study Population
Goede, Valentin, Bahlo, Jasmin, Kutsch, Nadine, Fischer, Kirsten, Fink, Anna Maria, Fingerle-Rowson, Guenter, Stilgenbauer, Stephan, Bergmann, Manuela A., Eichhorst, Barbara F., Hallek, Michael
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Alterations Of The Chemokine Microenvironment In Chronic Lymphocytic Leukemia
SEILER, TILL M, Aydin, Roland, Herold, Tobias, Holdenrieder, Stefan, Hallek, Michael, Hiddemann, Wolfgang, Dreyling, Martin, Bergmann, Manuela A.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Impact of Gender on Outcome after Chemoimmunotherapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) or Bendamustine Plus Rituximab (BR) in Patients with Chronic Lymphocytic Leukemia (CLL): A Meta-Analysis of Three Phase II/III Studies of the German CLL Study Group (GCLLSG)
Al-Sawaf, Othman, Robrecht, Sandra, Bahlo, Jasmin, Fink, Anna Maria, Cramer, Paula, Maurer, Christian, Bergmann, Manuela A., Dreyling, Martin H., Lange, Elisabeth, Kneba, Michael, Stilgenbauer, Stephan, Döhner, Hartmut, Kiehl, Michael G, Jäger, Ulrich, Wendtner, Clemens-Martin, Fischer, Kirsten, Hallek, Michael, Eichhorst, Barbara F., Hopfinger, Georg
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Overall Survival In Early Stage Chronic Lymphocytic Leukemia Patients With Treatment Indication Due To Disease Progression: Follow-Up Data Of The CLL1 Trial Of The German CLL Study Group (GCLLSG)
Bergmann, Manuela A., Busch, Raymonde, Eichhorst, Barbara, Buehler, Andreas, Fischer, Norbert, Eckart, Michael J, Vehling-Kaiser, Ursula, Jäger, Ulrich, Hopfinger, Georg, Wendtner, Clemens, Fischer, Kirsten, Emmerich, Bertold, Döhner, Hartmut, Hallek, Michael, Stilgenbauer, Stephan
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Role of Microenvironment-Associated Chemokines and Cytokines for Binet Stage A CLL Patients Included in a Prospective Trial (CLL1 trial) of the German CLL Study Group (GCLLSG): sIl2Ralpha Is An Independent Predictor of Progression-Free Survival (PFS)
Seiler, Till M, Aydin, Roland, Herold, Tobias, Busch, Raymonde, Schwarz, Markus, Holdenrieder, Stefan, Eichhorst, Barbara, Dohner, Hartmut, Stilgenbauer, Stephan, Hallek, Michael, Dreyling, Martin H., Bergmann, Manuela A.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
The Use of Chemoimmunotherapy Improves the Outcome of Patients with Chronic Lymphocytic Leukaemia (CLL) – a Metaanalysis of Five Trials of the German CLL Study Group (GCLLSG)
Cramer, Paula, Isfort, Susanne, Bahlo, Jasmin, Busch, Raymonde, Langerbeins, Petra, Fink, Anna-Maria, Goede, Valentin, Elter, Thomas, Bergmann, Manuela A., Stauch, Martina Beate, Stilgenbauer, Stephan, Wendtner, Clemens-Martin, Fischer, Kirsten, Hallek, Michael, Eichhorst, Barbara F.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Early Versus Deferred Treatment With Combined Fludarabine, Cyclophosphamide and Rituximab (FCR) Improves Event-Free Survival In Patients With High-Risk Binet Stage A Chronic Lymphocytic Leukemia – First Results Of a Randomized German-French Cooperative Phase III Trial
Schweighofer, Carmen D, Cymbalista, Florence, Müller, Carolin, Busch, Raymonde, Porcher, Raphael, Langerbeins, Petra, Cazin, Bruno, Fink, Anna-Maria, Dreyfus, Brigitte, Ibach, Stefan, Leprêtre, Stéphane, Fischer, Kirsten, Vehling-Kaiser, Ursula, Eichhorst, Barbara, Bergmann, Manuela A., Stilgenbauer, Stephan, Döhner, Hartmut, Leblond, Veronique, Hallek, Michael, Levy, Vincent
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Early and Risk-Adapted Therapy with Fludarabine in High-Risk Binet Stage A CLL Patients Prolongs Progression Free Survival but Not Overall Survival: Results of the CLL1 Protocol of the German CLL Study Group (GCLLSG)
Bergmann, Manuela A., Eichhorst, Barbara F., Busch, Raymonde, Doehner, Hartmut, Vehling-Kaiser, Ursula, Abenhardt, Wolfgang, Hallek, Michael, GCLLSG
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article
First-Line Treatment with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Improves Overall Survival (OS) in Previously Untreated Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Results of a Randomized Phase III Trial On Behalf of An International Group of Investigators and the German CLL Study Group
Hallek, Michael, Fingerle-Rowson, Guenter, Fink, Anna-Maria, Busch, Raymonde, Mayer, Jiri, Hensel, Manfred, Hopfinger, Georg, Hess, Georg, von Gruenhagen, Ulrich, Bergmann, Manuela A., Catalano, John, Zinzano, Pier Luigi, Cappio, Federico Caligaris, Seymour, John F, Berrebi, Alain, Jaeger, Ulrich, Cazin, Bruno, Trneny, Marek, Westermann, Anne, Wendtner, Clemens-Martin, Eichhorst, Barbara F., Staib, Peter, Boettcher, Sebastian, Ritgen, Matthias, Mendila, Myriam, Kneba, Michael, Doehner, Hartmut, Stilgenbauer, Stephan, Fischer, Kirsten
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
Prospective Evaluation of Prognostic Parameters in Early Stage Chronic Lymphocytic Leukemia (CLL): Results of the CLL1-Protocol of the German CLL Study Group (GCLLSG)
Bergmann, Manuela A., Eichhorst, Barbara F., Busch, Raymonde, Adorf, Dagmar, Stilgenbauer, Stephan, Eckart, Michael J., Wendtner, Clemens-Martin, Hallek, Michael, GCLLSG
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article
Immunochemotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Fludarabine and Cyclophosphamide (FC) Improves Response Rates and Progression-Free Survival (PFS) of Previously Untreated Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL)
Hallek, Michael, Fingerle-Rowson, Guenter, Fink, Anna- Maria, Busch, Raymonde, Mayer, Jiri, Hensel, Manfred, Hopfinger, Georg, Hess, Georg, von Gruenhagen, Ulrich, Bergmann, Manuela A., Catalano, John, Zinzani, Pier Luigi, Cappio, Federico Caligaris, Seymour, John Francis, Berrebi, Alain, Jaeger, Ulrich, Cazin, Bruno, Trneny, Marek, Westermann, Anne, Wendtner, Clemens-Martin, Eichhorst, Barbara F., Staib, Peter, Boettcher, Sebastian, Ritgen, Matthias, Stilgenbauer, Stephan, Mendila, Myriam, Kneba, Michael, Döhner, Hartmut, Fischer, Kirsten
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article